Axsome Therapeutics, Inc. (AXSM)
AXSM Price and Sentiment
AXSM Latest news
How Much Upside is Left in Axsome (AXSM)? Wall Street Analysts Think 144%
2021-11-10 11:28The average of price targets set by Wall Street analysts indicates a potential upside of 143.7% in Axsome (AXSM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Axsome (AXSM) Q3 Earnings Top, Pre-Launch Activities Continue
2021-11-09 11:28Axsome Therapeutics (AXSM) reports a narrower-than-expected Q3 loss. The company is actively preparing to support the commercial launch of its two under-review candidates, AXS-05 and AXS-07.
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q3 2021 Results - Earnings Call Transcript
2021-11-08 13:34Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q3 2021 Results - Earnings Call Transcript
Why Axsome Therapeutics Stock Is Rising Today
2021-11-08 12:37The company provided its third-quarter update.
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
2021-11-08 07:00Company to host conference call today at 8:00 AM Eastern
Biotech Stocks' Q3 Earnings on Nov 8: VTRS, EDIT & More
2021-11-05 11:28Let us look at four drug/biotech companies, VTRS, RDUS, AXSM and EDIT, which are gearing up for their earnings release.
Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021
2021-10-20 07:00Axsome to host conference call and webcast on Monday, November 8, 2021 at 8:00 AM Eastern Time
What's Happening With Axsome Therapeutics Stock?
2021-10-18 11:00Last month we discussed that Axsome Therapeutics stock is likely to continue to see higher levels after it rose 6% in a week following the U.S. FDA's acceptance of a new drug application for the company's migraine drug - AXS-07. AXSM stock has since then rallied 27% to levels of nearly $38 now.
Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million
2021-10-18 07:00$100 million now available upon the potential FDA approval of AXS-05
Why Axsome Therapeutics Stock Rocketed Higher This Week
2021-10-15 10:00Optimism among investors is growing for the possible approval of the biotech's MDD drug.